SC
Sequoia China
Beijing, ChinaFounded 2005
FintechBiotech & Life SciencesAIE-Commerce & MarketplaceRobotics & AutomationConsumerMobility & Transportation
Sequoia China, now operating as HongShan, focuses its investments on high-growth potential companies primarily within the technology (including AI, e-commerce, and fintech), healthcare, and consumer sectors. Their strategy involves a highly selective approach, meticulously analyzing market trends, management teams, and business model scalability, while investing across various stages from early-stage to growth and pre-IPO.
Average disclosed round size is $230.2M (across 76 rounds with reported amounts).
Portfolio
86
Fund Size
$55B
Top Stage
Series C
Last 12 Mo
0
Team
AC
Angelica Cheung
Investment Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
86 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Generation Lab | Pre-Seed | — | Jan 2024 |
 Noah Medical | Series B | $150M | Apr 2023 |
 Kaito | Seed | $5.3M | Feb 2023 |
 Airwallex | Series E | $400M | Oct 2022 |
| DDianxiaomi | Series D | $110M | Aug 2022 |
| PPacdora | Unknown | $8M | Aug 2022 |
| MMIRACLE MILES GROUP INC. | Series A | $100M | Jun 2022 |
| OOrderly Network | Strategic | $20M | Jun 2022 |
 ProfoundBio | Series A | $70M | Jun 2022 |
| SSwooshTransfer | Seed | — | Apr 2022 |
 Slope Finance | Series A | $8M | Feb 2022 |
 Amber Group | Series B | $200M | Feb 2022 |
 Taichi Graphics | Series A | $50M | Feb 2022 |
| SSyMap Medical Ltd. | Series D | $100M | Dec 2021 |
 Q-CTRL | Series B | $25M | Nov 2021 |
| Airwallex | Series E | $100M | Nov 2021 |
| HHT Aero | Series A | $500M | Oct 2021 |
 Hai Robotics | Series D | $200M | Sep 2021 |
| Hai Robotics | Series C | $200M | Sep 2021 |
| Hai Robotics | Series C | $200M | Sep 2021 |
 Outer | Series B | $50M | Sep 2021 |
| PPudu Robotics | Series C | $77M | Sep 2021 |
 Agile Robots | Series C | $220M | Sep 2021 |
 ShopperPlus | Series A | $17M | Sep 2021 |
 OPay | Series C | $400M | Aug 2021 |
Page 1 of 4
Top Co-Investors
Sequoia Capital22 shared
Tencent Investment12 shared
SoftBank Vision Fund10 shared
Hillhouse Capital9 shared
IDG Capital8 shared
Source Code Capital8 shared
Tiger Global Management7 shared
GGV Capital6 shared
5Y Capital5 shared
Blackbird5 shared
Felicis Ventures5 shared
VMS Group4 shared
Dragonfly4 shared
Lilly Asia Ventures4 shared
Meituan4 shared
LYFE Capital4 shared
DST Global3 shared
Shunwei Capital3 shared
Yunfeng Capital3 shared
WuXi Healthcare Ventures3 shared
Last updated: 12 April 2026